- Home
- YMAB vs PFL Comparison
YMAB vs PFL Comparison
Compare YMAB & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- PFL
- Stock Information
- Founded
- YMAB 2015
- PFL 2003
- Country
- YMAB United States
- PFL United States
- Employees
- YMAB N/A
- PFL N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- YMAB Health Care
- PFL Finance
- Exchange
- YMAB Nasdaq
- PFL Nasdaq
- Market Cap
- YMAB 386.7M
- PFL 374.5M
- IPO Year
- YMAB 2018
- PFL N/A
- Fundamental
- Price
- YMAB $8.57
- PFL $8.50
- Analyst Decision
- YMAB Buy
- PFL
- Analyst Count
- YMAB 10
- PFL 0
- Target Price
- YMAB $13.91
- PFL N/A
- AVG Volume (30 Days)
- YMAB 2.2M
- PFL 113.7K
- Earning Date
- YMAB 08-08-2025
- PFL 01-01-0001
- Dividend Yield
- YMAB N/A
- PFL 11.53%
- EPS Growth
- YMAB N/A
- PFL N/A
- EPS
- YMAB N/A
- PFL N/A
- Revenue
- YMAB $85,385,000.00
- PFL N/A
- Revenue This Year
- YMAB N/A
- PFL N/A
- Revenue Next Year
- YMAB $13.97
- PFL N/A
- P/E Ratio
- YMAB N/A
- PFL N/A
- Revenue Growth
- YMAB N/A
- PFL N/A
- 52 Week Low
- YMAB $3.55
- PFL $6.98
- 52 Week High
- YMAB $16.11
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- YMAB 81.31
- PFL 59.18
- Support Level
- YMAB $8.50
- PFL $8.42
- Resistance Level
- YMAB $8.56
- PFL $8.54
- Average True Range (ATR)
- YMAB 0.02
- PFL 0.04
- MACD
- YMAB -0.12
- PFL -0.00
- Stochastic Oscillator
- YMAB 83.33
- PFL 66.67
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.